JP7844438B2 - フロセミドを使用した治療方法 - Google Patents

フロセミドを使用した治療方法

Info

Publication number
JP7844438B2
JP7844438B2 JP2023507241A JP2023507241A JP7844438B2 JP 7844438 B2 JP7844438 B2 JP 7844438B2 JP 2023507241 A JP2023507241 A JP 2023507241A JP 2023507241 A JP2023507241 A JP 2023507241A JP 7844438 B2 JP7844438 B2 JP 7844438B2
Authority
JP
Japan
Prior art keywords
approximately
mmol
hour
administration
furosemide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023507241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023536730A5 (https=
JP2023536730A (ja
Inventor
モール，ジョン，エフ．
タッカー，ジョン
ハスマン，マイケル
ペコレッリ，エリック，マーク
Original Assignee
エスシーファーマシューティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エスシーファーマシューティカルズ インコーポレイテッド filed Critical エスシーファーマシューティカルズ インコーポレイテッド
Publication of JP2023536730A publication Critical patent/JP2023536730A/ja
Publication of JP2023536730A5 publication Critical patent/JP2023536730A5/ja
Application granted granted Critical
Publication of JP7844438B2 publication Critical patent/JP7844438B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
JP2023507241A 2020-08-05 2021-08-05 フロセミドを使用した治療方法 Active JP7844438B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063061518P 2020-08-05 2020-08-05
US63/061,518 2020-08-05
PCT/US2021/044723 WO2022031959A1 (en) 2020-08-05 2021-08-05 Methods of treatment using furosemide

Publications (3)

Publication Number Publication Date
JP2023536730A JP2023536730A (ja) 2023-08-29
JP2023536730A5 JP2023536730A5 (https=) 2024-08-14
JP7844438B2 true JP7844438B2 (ja) 2026-04-13

Family

ID=77774970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507241A Active JP7844438B2 (ja) 2020-08-05 2021-08-05 フロセミドを使用した治療方法

Country Status (9)

Country Link
US (1) US20230270759A1 (https=)
EP (2) EP4192473B1 (https=)
JP (1) JP7844438B2 (https=)
CN (1) CN116322704A (https=)
AU (1) AU2021320308A1 (https=)
CA (1) CA3190585A1 (https=)
IL (1) IL300152A (https=)
MX (1) MX2023001385A (https=)
WO (1) WO2022031959A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024512650A (ja) * 2021-04-02 2024-03-19 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下注入
EP4648761A1 (en) * 2023-01-09 2025-11-19 scPharmaceuticals Inc. Methods of treatment using loop diuretics

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016515623A (ja) 2013-04-05 2016-05-30 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下投与用の医薬製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6595961B2 (en) * 2001-04-16 2003-07-22 Becton, Dickinson And Company Sterilizable transfer or storage device for medicaments, drugs and vaccines
ES3041602T3 (en) * 2018-12-10 2025-11-13 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016515623A (ja) 2013-04-05 2016-05-30 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下投与用の医薬製剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JACC Basic Transl Sci，2018年，3(1):25-34
Wedbush PacGrow Healthcare Conference sc Pharmaceuticals 資料，2019年08月14日

Also Published As

Publication number Publication date
MX2023001385A (es) 2023-03-03
EP4192473A1 (en) 2023-06-14
CN116322704A (zh) 2023-06-23
EP4681736A2 (en) 2026-01-21
IL300152A (en) 2023-03-01
JP2023536730A (ja) 2023-08-29
EP4681736A3 (en) 2026-03-25
US20230270759A1 (en) 2023-08-31
EP4192473B1 (en) 2025-12-03
CA3190585A1 (en) 2022-02-10
AU2021320308A1 (en) 2023-03-02
WO2022031959A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
JP7738696B2 (ja) フロセミドの濃縮液体医薬製剤及びそれを投与する方法
JP7844438B2 (ja) フロセミドを使用した治療方法
KR20260035797A (ko) 루프 이뇨제를 사용한 치료 방법
WO2024064027A1 (en) Liquid pharmaceutical formulations of loop diuretics and methods of administering the same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251120

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260303

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260401

R150 Certificate of patent or registration of utility model

Ref document number: 7844438

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150